Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.
Millions of adults with obesity in the U.S. would have increased access to the widely popular drugs.
Under the proposal, those who are considered obese—anyone with a body mass index of 30 or higher—would qualify for coverage under Medicare and Medicaid, while others may already be covered if they have diabetes or are at risk of stroke or heart disease, the Biden administration announced.
This is a developing story.
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.